Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer
Crossref DOI link: https://doi.org/10.1007/s00280-015-2814-8
Published Online: 2015-07-01
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Suleiman, Yaman
Mahipal, Amit
Shibata, David
Siegel, Erin M.
Jump, Helen
Fulp, William J.
Springett, Gregory M.
Kim, Richard
Text and Data Mining valid from 2015-07-01